Cibus Inc./$CBUS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
- Ticker
- $CBUS
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 118
- Headquarters
- San Diego, United States
- Website
- www.cibus.com
Cibus Inc. Metrics
BasicAdvanced
$89M
-
-$1.58
1.62
-
Price and volume
Market cap
$89M
Beta
1.62
52-week high
$4.19
52-week low
$1.07
Average daily volume
93K
Financial strength
Current ratio
1.624
Quick ratio
1.493
Long term debt to equity
19.091
Total debt to equity
19.339
Interest coverage (TTM)
-1.46%
Profitability
EBITDA (TTM)
-48.869
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-2,258.89%
Operating margin (TTM)
-1,240.90%
Effective tax rate (TTM)
-0.01%
Revenue per employee (TTM)
$40,000
Management effectiveness
Return on assets (TTM)
-10.22%
Return on equity (TTM)
-223.16%
Valuation
Price to revenue (TTM)
16.568
Price to book
5.99
Price to tangible book (TTM)
-0.36
Price to free cash flow (TTM)
-1.555
Free cash flow yield (TTM)
-64.32%
Free cash flow per share (TTM)
-0.746
Growth
Revenue change (TTM)
-10.30%
Earnings per share change (TTM)
-81.78%
3-year revenue growth (CAGR)
137.86%
3-year earnings per share growth (CAGR)
-52.24%
Cibus Inc. Financial Performance
Revenues and expenses
Cibus Inc. Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.